A 70-year-old female was hospitalized with intermittent fevers of four weeks duration. She had a past medical history of breast cancer (in remission) and recently diagnosed squamous cell carcinoma of the cervix, stage II-B. She had a PICC placed to receive chemotherapy with gemcitabine and cisplatin two months prior to admission. She experienced increasing episodes of intermittent fevers after PICC placement and was admitted for further management of symptoms.
Initial workup revealed positive blood culture from PICC for Pantoea agglomerans and peripheral blood culture with gram positive bacilli. The PICC line was removed on the second day of hospital admission and culture of the catheter tip also grew gram positive bacilli. The latter organism only grew at 72 hours and a gram stain determined gram positive, beaded, filamentous bacilli (Figures 1 and 2 ). The organism was suspected to be a Rapidly Growing Mycobacterium (RGM) based on colony morphology smooth, white to salmon colored colonies were observed (Figure 3 ). Fluorescent and Kinyoun stains were negative. The organism was sent for definitive identification via 16S rRNA sequencing, based on the need for accurate diagnosis. The patient was initially started on levofloxacin to cover the P. agglomerans and empiric vancomycin to cover the gram positive bacillus. Once the presumed RGM was identified during the course of the hospitalization, amikacin and azithromycin were added to the patient's antimicrobial regimen and the vancomycin was discontinued. The patient experienced pruritus and lip swelling closely associated with administration of her azithromycin dose. Azithromycin was switched to cefoxitin and levofloxacin and amikacin were continued. A CT of the abdomen and pelvis did not reveal an occult abscess. The P. agglomerans, which has been described in health care associated infections and was formerly in the Enterobacter sp group, was not felt to have a major pathogenic role, as the PICC tip and subsequent cultures never grew this organism. The patient was clinically stable and no longer having fevers at the time of discharge from the hospital. Ten days after discharge, results of the 16S rRNA sequencing became available the presumed RGM was then correctly identified as Gordonia sp. The patient's infusion of amikacin had been suboptimal and, based on literature review and susceptibilities of the Gordonia isolate (susceptible to amikacin, amoxicillin-clavulanate, cefepime, ceftriaxone, ciprofloxacin, clarithromycin, imipenem, linezolid, moxifloxacin, tobramycin, trimethropim-sulfa, doxycycline, minocycline, tigecycline), her regimen was simplified to ceftriaxone and oral ciprofloxacin. 
Discussion
Gordonia sp are aerobic, thin, beaded gram positive bacilli [1] . They are weakly acid fast due to the presence of mycolic acid in their cell wall structure [1] .
Gordonia was first proposed as a new genus by Tsukamura in 1971. Twenty-nine species of Gordonia have been described since then [3] . The organism was first isolated from water inside an automobile tire and the first clinical case was described by Kempf et al., in a bone marrow transplant recipient [4] .
Genomic analysis of the organism has shown its ability to colonize indwelling catheters, due to the production of biosurfactants and biofilm. This allows for adhesion to rubber material in catheters. Gordonia sp are able to utilize rubber as their only source of carbon and represent the most potent rubber degrader tested to date [4] . Gordonia infections have been described in the immunocompromised, in patients with underlying malignancy and in those with chronic indwelling catheters. There have been cases described in immunocompetent hosts as well [5] .
Grisold et al., [6] described Catheter Related Bloodstream Infection (CRBSI) and pneumonia in a 24 year old male with history of chronic anabolic steroid use. Lesens et al., [7] described the first case of Gordonia sp endocarditis in a patient with severe hemoglobinopathy, splenectomy and indwelling central venous catheter. Verma et al., [8] subsequently reported Gordonia polyisoprenivorans native valve endocarditis in a patient with underlying myelodysplastic syndrome and Osler Weber Rendu syndrome.
Four cases of Gordonia bacteremia and one case of meningitis were studied by Blaschke et al., [9] in a pediatric series. Five cases of G. terrae CRBSI, all with underlying malignancy, were identified by Pham et al., [10] . Brust et al., [11] analyzed 5 cases of Gordonia bacteremia, mostly G. terrae. Gupta et al., [12] described a 17-year-old female with underlying leukemia and Broviac catheter related Gordonia bacteremia, initially misidentified as Rhodococcus equi.
Paravertebral abscess and G bronchialis bacteremia in conjunction with poorly controlled diabetes mellitus and asthma was analyzed by Sng et al., [2] . Lai et al., [13] explored 9 cases of various Gordonia infections, including CRBSI, cellulitis, traumatic wound infection and infective keratitis.
Granulomatous skin infections, brain abscesses, granulomatous mastitis and mycetoma of the hand have also been described in association with Gordonia [6] .
Misidentification of Gordonia as Nocardia, Rhodococcus, Corynebacterium or non-tuberculous Mycobacteria poses a significant challenge for appropriate clinical management. A delay in diagnosis can result in dismissal as a commensal organism or in inadequate antimicrobial therapy. Reported susceptibility patterns are variable. In general, Gordonia sp are susceptible to imipenem, ciprofloxacin, vancomycin, amoxicillin-clavulanate, amikacin and linezolid and may be resistant to tetracyclines, trimethropim-sulfamethoxazole, clarithromycin, rifampin and cefoxitin [2] [3] [4] [5] 7, 8, 14] . Duration of treatment is between 6-12 weeks [3] , with catheter removal being suggested in children [8] . There are no clear guidelines for catheter removal in adults, although Lesens et al., [7] noted successful retention of central venous catheter in the setting of bacteremia and Gordonia sp native valve endocarditis after 6 weeks of intravenous antibiotic therapy.
In conclusion, there is a need for increased awareness of unusual pathogenic organisms in patients who are immunocompromised or have underlying malignancy in the setting of chronic indwelling catheters or central lines. In patients with bacteremia caused by gram positive bacilli that are difficult to identify or have atypical morphology, we suggest use of 16S rRNA sequencing for definitive organism identification. Empiric initiation of a combination antimicrobial regimen, pending organism identification, such as a carbapenem or quinolone with an aminoglycoside would be most likely to address the main etiological considerations for the clinical scenario in question. Investigation for endocarditis should be considered in patients with Gordonia sp bloodstream infections. Furthermore, catheter removal should be generally encouraged in order to improve the odds of complete resolution of infection and minimize its dissemination.
